Visión generalGráficoNoticiasTraderScreen

UBS Call 12.5 F 20.09.2024/  CH1326170532  /

Frankfurt Zert./UBS
28/06/2024  13:03:22 Diferencia-0.080 Bid13:17:13 Ask13:17:13 Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
0.430EUR -15.69% 0.450
Volumen de oferta: 2,500		 0.650
Tamaño/ Volumen/ Formato de Ask: 2,500		 Ford Motor Company 12.50 USD 20/09/2024 Call
TeleTrader 13:43 River Seine unswimmable, water test shows
GlobeNewswire 13:30 DeFi Technologies’ Subsidiary Valour Inc. Debuts World's First CORE ETP and Expands World’s First He...
GlobeNewswire 13:30 Intermap Technologies Announces Voting Results of the Annual Meeting of Shareholders
GlobeNewswire 13:30 Old Dominion University Launches Mobile Credentials with CBORD and Allegion
GlobeNewswire 13:23 Troilus Files NI 43-101 Technical Report for the Troilus Project’s Feasibility Study
TeleTrader 13:20 Israeli FM Katz invited to NATO summit
GlobeNewswire 13:00 Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on Intern...
GlobeNewswire 13:00 CryptoSafe Unveils Safe Pay: A Game-Changer in Cryptocurrency Payment Solutions
GlobeNewswire 13:00 OTC Markets Group Welcomes Golden Metal Resources PLC to OTCQX
GlobeNewswire 13:00 Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for...
GlobeNewswire 13:00 Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
GlobeNewswire 13:00 Asset Entities Inc. Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Pri...
GlobeNewswire 13:00 Plug to Receive Federal Clean Hydrogen Production Tax Credit at Georgia Hydrogen Facility
GlobeNewswire 13:00 OTC Markets Group Welcomes Endo, Inc. to OTCQX
GlobeNewswire 13:00 Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Di...
GlobeNewswire 13:00 23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
GlobeNewswire 13:00 Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphom...
GlobeNewswire 13:00 Amwell Announces Reverse Stock Split
GlobeNewswire 13:00 RAIR Technologies Empowers Developers to Build Web3 Applications through India’s Largest Hackathon
GlobeNewswire 13:00 Esperion Announces Monetization of European Royalties and Concurrent Payoff and Termination of Exist...
GlobeNewswire 12:57 Apellis Plans to Seek Re-Examination Following Negative CHMP Opinion for Pegcetacoplan for Geographi...
GlobeNewswire 12:54 Crown Crafts Announces Financial Results for Fourth Quarter and Full Year Fiscal 2024
TeleTrader 12:54 Trump Media jumps 10% in premarket after first debate
GlobeNewswire 12:49 OKX Marketplace and Layer3 to Give Away 50,000 Polygon-Based 'Layer3 x OKX Genesis' NFTs
GlobeNewswire 12:31 AB Science provides an update on the application for conditional marketing authorisation of masitini...